CRISPR Therapeutics AG and Vertex Pharmaceuticals are one step closer to gaining approval for their CRISPR/Cas9 gene editing therapy for Sickle Cell Disease and beta thalassemia. An FDA Advisory ...
While there’s no shortage of startups aiming to replace Google with AI-powered search (we’re looking at you, Perplexity), a startup called Exa has a different idea: a Google for AI. Humans aren’t the ...
Exa Labs Inc., a startup with a search engine that artificial intelligence models can use to browse the web, has raised $85 million in funding. Benchmark led the Series B round. The venture capital ...
Exagamglogene autotemcel (exa-cel) is a nonviral cell therapy designed to reactivate fetal hemoglobin synthesis by means of ex vivo clustered regularly interspaced short palindromic repeats ...
CRISPR, the gene-editing technology that has revolutionized biological research, is finally available as a medical treatment with regulatory approval. On December 8 the U.S. Food and Drug ...
When Jeffrey Wang posted to X last week asking if anyone wanted to go in on an order of fancy-but-affordable office nap pods, he didn’t expect the post to go viral. He said so many others wanted in, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback